Inventor
Suresh C. Srivastava
Inventor
Setauket, NY, US
Overview
Patents· 59 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
A61Kprimary
A61KPreparations for medical, dental or toiletry purposes20%
C07HSugars18%
C07BGeneral methods of organic chemistry8%
C07CAcyclic or carbocyclic compounds8%
C07DHeterocyclic compounds7%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations6%
Y02PClimate change mitigation technologies in the production or processing of goods6%
C12NMicroorganisms or enzymes5%
C07FAcyclic, carbocyclic or heterocyclic compounds containing elements other than carbon, hydrogen, halogen, oxygen, nitrogen, sulfur, selenium or tellurium4%
G21GConversion of chemical elements3%
PatentTitleYear
10,973,312Application element for an applicator202110,167,308Highly efficient synthesis of long RNA using reverse direction approach20199,969,764Dithiolane functionalized nucleoside amidites and supports for stronger immobilization of bio-molecules on solid surfaces20189,884,885'Synthesis of labile base protected-modified deoxy and modified ribo nucleosides, corresponding phosphoramidites and supports and their use in high purity oligonucleotide synthesis'20189,788,408'Targets and methods for target preparation for radionuclide production'20179,718,855'Nucleosides and oligonucleotides for studies on reversal of cytotoxic and mutagenic damage of DNA and as diagnostics tools'20179,623,129'Methods and therapies for treating inflammatory conditions with exposed collagen'20179,605,261'RNA synthesis—phosphoramidites for synthetic RNA in the reverse direction, and application in convenient introduction of ligands, chromophores and modifications of synthetic RNA at the 3′-end'20179,512,162'Synthesis of deuterated ribo nucleosides, N-protected phosphoramidites and oligonucleotides'20169,493,773'Synthesis of deuterated ribo nucleosides, N-protected phosphoramidites, and oligonucleotides'20169,441,002'Dithiolane based thiol modifier for labeling and stronger immobilization of bio-molecules on solid surfaces'20169,365,607'Synthesis of deuterated ribo nucleosides, N-protected phosphoramidites, and oligonucleotides'20169,045,521'Synthesis of deuterated ribo nucleosides N-protected phosphoramidites, and oligonucleotides'20158,981,076'Synthesis of N-FMOC protected deoxy nucleosides, ribo nucleosides, modified deoxy and ribo nucleosides, and phosphoramidites, and their use in oligonucleotide synthesis'20158,933,214'RNA synthesis—phosphoramidites for synthetic RNA in the reverse direction, and application in convenient introduction of ligands, chromophores and modifications of synthetic RNA at the 3′-end'20158,859,754'Synthesis of deuterated ribo nucleosides, N-protected phosphoramidites, and oligonucleotides'20148,834,338'Dosimetry implant for treating restenosis and hyperplasia'20148,785,619'Nucleosides and oligonucleotides for studies on reversal of cytotoxic and mutagenic damage of DNA potential diagnostics tools'20148,778,996'Method of treating a human being for a class of neurological defects and seizure disorders'20148,705,681'Process and targets for production of no-carrier-added radiotin'20148,618,279'Synthesis of 2′,3′— and 3′,5′—cyclic phosphate mono-and oligonucleotides'20138,541,569'Phosphoramidites for synthetic RNA in the reverse direction, efficient RNA synthesis and convenient introduction of 3\'-end ligands, chromophores and modifications of synthetic RNA'20138,530,634'Method of oligonucleotide labeling using cycloaddition reaction'20138,518,992'Method of synthesis and purification of N-6-trimethyl-L-lysine and derivative compounds'20138,389,577'Method of treating a human being for a class of metabolic defects and energy production disorders'20138,309,707'RNA synthesis-phosphoramidites for synthetic RNA in the reverse direction, and application in convenient introduction of ligands, chromophores and modifications of synthetic RNA at the 3′-end'20128,290,110'Targets and methods for target preparation for radionuclide production'20128,114,264'Method of electroplating a conversion electron emitting source on implant'20128,097,064'Methods for chemical recovery of non-carrier-added radioactive tin from irradiated intermetallic Ti-Sb targets'20127,956,169'Synthesis of novel azo-dyes and their use in oligonucleotide synthesis'20117,932,287'Therapeutic compositions and uses'20117,846,436'Oligonucleotides and related compounds'20106,541,514'Process for the manufacture of 117Sn diethylenetriaminepentaacetic acids'20036,517,810'Therapeutic tin-117m compositions'20036,503,477'Radiopharmaceutical compositions'20036,231,832'Radiopharmaceutical stannic Sn-117m chelate compositions and methods of use'20016,022,522'Rigid bifunctional chelating agents'20006,015,886'Oligonucleotide phosphate esters'20006,004,532'Formulation for Tin-.sup.117m /diethylenetriaminepentaacetic acids'19995,853,695'Method for palliation of pain in human bone cancer using therapeutic tin-117m compositions'19985,783,169'Rigid bifunctional chelating agents'19985,744,595'Propargyl modified nucleosides and nucleotides'19985,639,879'Macrocyclic polyaminocarboxylates for stable radiometal antibody conjugates for therapy, spect and pet imaging'19975,635,157'Synthesis of 4-substituted-trans-1,2-diaminocyclohexyl polyaminocarboxylate metal chelating agents for the preparation of stable radiometal antibody immunoconjugates for therapy and spect and pet imaging'19975,428,156'Synthesis of macrocyclic polyaminocarboxylates and their use for preparing stable radiometal antibody immunoconjugates for therapy, spect and pet imaging'19955,334,729'Stable radiometal antibody immunoconjugates'19945,292,938'Synthesis of 4-substituted-trans-1, 2-diaminocyclohexyl polyaminocarboxylate metal chelating agents for the preparation of stable radiometal antibody immunoconjugates for therapy and spect and pet imaging'19945,225,181'Radiolabeled antiplatelet monoclonal antibody for imaging in-vivo thrombi'19935,214,135'N-protected-2\'-O-methyl-ribonucleosides and N-protected 2\'-O-methyl-3\'-cyanoethyl-N-,N-diisopropyl phosphoramidite ribonucleosides'19935,116,470'Preparation of high specific activity technetium-96'19925,116,597'Kit for the selective labeling of red blood cells in whole blood with .sup.9 TC'19925,089,663'Cyclohexyl-triethylenetetraamine hexacetic acid'19925,021,571'Cyclohexyl EDTA monoanhydride'1991H0000819'Palladium-109 labeled anti-melanoma monoclonal antibodies'1990H0000735'Lead-203 as a label for radioimaging'19904,755,375'Method and kit for the selective labeling of red blood cells in whole blood with TC-99M'19884,533,541'Tin-117m-labeled stannic (Sn.sup.4+) chelates'19854,500,508'Radionuclide labeled lymphocytes for therapeutic use'19854,448,762'Complex of transferrin with ruthenium for medical applications'1984Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
1984–2017Based in Setauket, NY, US· patent location history
1988–1997Patents assigned to ASS UNIVERSITIES INC (8)· patent assignee history
1990–2018Patents assigned to SRIVASTAVA SURESH C (17)· patent assignee history
1993–2019Patents assigned to CHEMGENES CORP (20)· patent assignee history
1993–2019Based in Burlington, MA, US· patent location history
1998–2017Patents assigned to BROOKHAVEN SCIENCE ASS LLC (13)· patent assignee history
2014–2016Patents assigned to ASED LLC (5)· patent assignee history
2021Based in New Delhi, IN· patent location history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| CHEMGENES CORP | 20 | 1993–2019 |
| SRIVASTAVA SURESH Cself | 17 | 1990–2018 |
| BROOKHAVEN SCIENCE ASS LLC | 13 | 1998–2017 |
| ASS UNIVERSITIES INC | 8 | 1988–1997 |
| ASED LLC | 5 | 2014–2016 |
Locations
| Location | Patents | Span |
|---|---|---|
| Setauket, New York, US | 31 | 1984–2017 |
| Burlington, Massachusetts, US | 27 | 1993–2019 |
| New Delhi, IN | 1 | 2021 |